ProfileGDS4718 / 205297_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 64% 66% 55% 63% 57% 54% 54% 66% 62% 63% 56% 83% 57% 52% 54% 67% 60% 55% 55% 64% 64% 58% 59% 64% 66% 54% 56% 52% 59% 57% 61% 54% 72% 60% 51% 53% 59% 76% 78% 56% 66% 58% 51% 58% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3971364
GSM549102patient 115, normal, homogenized [OPG study]6.5585766
GSM549104patient 119, normal, homogenized [OPG study]5.8028355
GSM549108patient 138, normal, homogenized [OPG study]6.309163
GSM549119patient 077, normal, homogenized [OPG study]5.9241257
GSM549133patient 032, cancer, homogenized [OPG study]5.680854
GSM549139patient 042, cancer, homogenized [OPG study]5.7309954
GSM549099patient 107, normal, homogenized [OPG study]6.5441466
GSM549109patient 139, normal, homogenized [OPG study]6.271562
GSM549110patient 046, normal, homogenized [OPG study]6.3225163
GSM549114patient 063, normal, homogenized [OPG study]5.8040156
GSM549122patient 082, normal, homogenized [OPG study]8.220983
GSM549134patient 033, cancer, homogenized [OPG study]5.8813657
GSM549136patient 036, cancer, homogenized [OPG study]5.5626152
GSM549140patient 044, cancer, homogenized [OPG study]5.7468554
GSM549111patient 047, normal, homogenized [OPG study]6.6507567
GSM549113patient 057, normal, homogenized [OPG study]6.0856460
GSM549132patient 031, cancer, homogenized [OPG study]5.8100455
GSM549137patient 038, cancer, homogenized [OPG study]5.7924655
GSM549142patient 047, cancer, homogenized [OPG study]6.4776864
GSM549100patient 110, normal, homogenized [OPG study]6.3679364
GSM549107patient 135, normal, homogenized [OPG study]5.9969658
GSM549115patient 068, normal, homogenized [OPG study]6.0466359
GSM549116patient 072, normal, homogenized [OPG study]6.4518464
GSM549120patient 078, normal, homogenized [OPG study]6.5837866
GSM549131patient 030, cancer, homogenized [OPG study]5.7060454
GSM549118patient 074, normal, homogenized [OPG study]5.8593256
GSM549129patient 027, cancer, homogenized [OPG study]5.6715152
GSM549123patient 088, normal, homogenized [OPG study]6.0780559
GSM549124patient 006, cancer, homogenized [OPG study]5.9756657
GSM549126patient 015, cancer, homogenized [OPG study]6.1506561
GSM549128patient 025, cancer, homogenized [OPG study]5.7549954
GSM549103patient 117, normal, homogenized [OPG study]6.9353272
GSM549117patient 073, normal, homogenized [OPG study]6.0617360
GSM549138patient 041, cancer, homogenized [OPG study]5.5418951
GSM549141patient 045, cancer, homogenized [OPG study]5.6386653
GSM549130patient 028, cancer, homogenized [OPG study]6.0272759
GSM549101patient 111, normal, homogenized [OPG study]7.438976
GSM549105patient 128, normal, homogenized [OPG study]7.5800778
GSM549106patient 134, normal, homogenized [OPG study]5.8196156
GSM549112patient 048, normal, homogenized [OPG study]6.5301766
GSM549125patient 011, cancer, homogenized [OPG study]5.98658
GSM549127patient 024, cancer, homogenized [OPG study]5.5738651
GSM549135patient 035, cancer, homogenized [OPG study]5.9691558